0001104659-22-050451.txt : 20220609 0001104659-22-050451.hdr.sgml : 20220609 20220426171813 ACCESSION NUMBER: 0001104659-22-050451 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-406-3700 MAIL ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 CORRESP 1 filename1.htm

 

Cara Therapeutics, Inc.

4 Stamford Plaza

107 Elm Street, 9th Floor

Stamford, Connecticut 06902

 

April 26, 2022

 

Via EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn:     Michael Davis

 

  Re:

 Request to Withdraw Acceleration Request of Cara Therapeutics, Inc., (the “Company”), dated April 22, 2022 for the Registration Statement on Form S-3 (File No. 333-263165) 

 

Mr. Davis,

 

On behalf of the Company, I hereby formally request the withdrawal of the acceleration request of Cara Therapeutics, Inc. with respect to the above referenced registration statement, submitted via Edgar on April 22, 2022.

 

Thank you for the Staff’s cooperation in connection with this matter.

 

  Very truly yours,
   
  Cara Therapeutics, Inc.
     
  By:

/s/ Christopher Posner 

    Christopher Posner
    Chief Executive Officer and Director

 

cc:       Darren DeStefano, Cooley LLP